Literature DB >> 26995725

Larval development assays reveal the presence of sub-populations showing high- and low-level resistance in a monepantel (Zolvix®)-resistant isolate of Haemonchus contortus.

Ali Raza1, Jane Lamb2, Michael Chambers2, Peter W Hunt3, Andrew C Kotze4.   

Abstract

Resistance to the amino-acetonitrile derivative monepantel has been reported in several species of gastrointestinal nematodes over recent years. We were interested in the use of in vitro assays with free-living worm life-stages to detect resistance to this drug. We therefore used larval development and larval migration assays to examine dose response relationships for the drug against two susceptible and one resistant isolate of Haemonchus contortus. The resistant isolate was established by laboratory propagation of the survivors of a field treatment with Zolvix(®) that had originally resulted in a drug efficacy of over 99%. Drug efficacy against this field-derived laboratory-propagated resistant isolate in vivo was approximately 15%. The larval development assay proved able to discriminate between the susceptible and resistant isolates, with larvae of the resistant isolate showing an ability to develop at higher drug concentrations than the two susceptible isolates. The resistant isolate showed the presence of two distinct subpopulations, separated by a plateau in the dose-response curve. Sub-population 1 (approximately 40% of the total population) showed a low level of resistance with an IC50 increased approximately 7-fold compared to the baseline susceptible isolate, while sub-population 2 (the remaining 60% of the total population) showed an IC50 increased over 1000-fold compared to the baseline susceptible isolate. This level of resistance is unusually high for any gastrointestinal nematode species in drug dose-response in vitro assays. In contrast, the migration assay could not discriminate between the three isolates, with migration not reduced to zero at any of the drug concentrations tested. This study demonstrates that a larval development assay is able to detect resistance to monepantel in H. contortus, and that resistance can exist in two distinct forms. This suggests that at least two separate monepantel resistance mechanisms are acting within the worm isolate studied here, with one or more mechanisms conferring a much higher level of resistance than the other(s). Crown
Copyright © 2016. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Development; Haemonchus contortus; In vitro assay; Migration; Monepantel; Resistance

Mesh:

Substances:

Year:  2016        PMID: 26995725     DOI: 10.1016/j.vetpar.2016.02.031

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  10 in total

1.  Mutations in the Hco-mptl-1 gene in a field-derived monepantel-resistant isolate of Haemonchus contortus.

Authors:  Neil H Bagnall; Angela Ruffell; Ali Raza; Timothy P Elliott; Jane Lamb; Peter W Hunt; Andrew C Kotze
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-05-04       Impact factor: 4.077

2.  Investigating the function and possible biological role of an acetylcholine-gated chloride channel subunit (ACC-1) from the parasitic nematode Haemonchus contortus.

Authors:  Micah K Callanan; Sarah A Habibi; Wen Jing Law; Kristen Nazareth; Richard L Komuniecki; Sean G Forrester
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-10-27       Impact factor: 4.077

3.  Extreme-QTL mapping of monepantel resistance in Haemonchus contortus.

Authors:  Simone Cristina Méo Niciura; Polyana Cristine Tizioto; Caroline Valério Moraes; Giovanna Gabrielle Cruvinel; Ana Cláudia Alexandre de Albuquerque; Raul Costa Mascarenhas Santana; Ana Carolina de Souza Chagas; Sergio Novita Esteves; Magda Vieira Benavides; Alessandro Francisco Talamini do Amarante
Journal:  Parasit Vectors       Date:  2019-08-14       Impact factor: 3.876

4.  Multiple drug resistance in the canine hookworm Ancylostoma caninum: an emerging threat?

Authors:  Pablo D Jimenez Castro; Sue B Howell; John J Schaefer; Russell W Avramenko; John S Gilleard; Ray M Kaplan
Journal:  Parasit Vectors       Date:  2019-12-09       Impact factor: 3.876

5.  Sertraline as a new potential anthelmintic against Haemonchus contortus: toxicity, efficacy, and biotransformation.

Authors:  Markéta Zajíčková; Lukáš Prchal; Martina Navrátilová; Nikola Vodvárková; Petra Matoušková; Ivan Vokřál; Linh Thuy Nguyen; Lenka Skálová
Journal:  Vet Res       Date:  2021-12-11       Impact factor: 3.683

6.  First Report of Multiple Drug-resistant Gastrointestinal Nematodes of Sheep in Arbat District, Sulaymaniyah, Iraq Detected By in Vivo and in Vitro Methods.

Authors:  Hiewa Othman Dyary; Hamasalih Qadir Banaz
Journal:  J Vet Res       Date:  2021-08-19       Impact factor: 1.744

7.  Comparative analysis on transcriptomics of ivermectin resistant and susceptible strains of Haemonchus contortus.

Authors:  Waresi Tuersong; Caixian Zhou; Simin Wu; Peixi Qin; Chunqun Wang; Wenda Di; Lu Liu; Hui Liu; Min Hu
Journal:  Parasit Vectors       Date:  2022-05-07       Impact factor: 4.047

8.  Increased expression of ATP binding cassette transporter genes following exposure of Haemonchus contortus larvae to a high concentration of monepantel in vitro.

Authors:  Ali Raza; Neil H Bagnall; Abdul Jabbar; Steven R Kopp; Andrew C Kotze
Journal:  Parasit Vectors       Date:  2016-09-29       Impact factor: 3.876

9.  Metabolism of albendazole, ricobendazole and flubendazole in Haemonchus contortus adults: Sex differences, resistance-related differences and the identification of new metabolites.

Authors:  Lucie Raisová Stuchlíková; Petra Matoušková; Ivan Vokřál; Jiří Lamka; Barbora Szotáková; Anna Sečkařová; Diana Dimunová; Linh Thuy Nguyen; Marián Várady; Lenka Skálová
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-01-31       Impact factor: 4.077

10.  Genotypic characterisation of monepantel resistance in historical and newly derived field strains of Teladorsagia circumcincta.

Authors:  Frank Turnbull; Eileen Devaney; Alison A Morrison; Roz Laing; Dave J Bartley
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-10-06       Impact factor: 4.077

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.